
According to data from Benzinga Pro, during Q1, HOOKIPA Pharma's (NASDAQ:HOOK) reported sales totaled $1.45 million. Despite a 15.38% increase in earnings, the company posted a loss of $17.97 million. HOOKIPA Pharma collected $3.90 million in revenue during Q4, but reported earnings showed a $21.23 million loss.